Andrea Rubbert-Roth

19PUBLICATIONS
76CO-AUTHORS
Aboriginal and Torres Strait Islander medicine and treatmentsGene expression (incl. microarray and other genome-wide approaches)Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 23, 2026
Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries.

|Nov 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives.

Romain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert

|Apr 02, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.

Daniel Blockmans, Sara K Penn, Arathi R Setty

|Jul 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

Roy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman

|Jul 20, 2024
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.

Andrea Rubbert-Roth, Koji Kato, Boulos Haraoui

|Dec 06, 2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.

Adrian Ciurea, Andrea Götschi, René Bräm

Pageof 4

Frequent Collaborators

5 joint publications

Axel Finckh

4 joint publications

Adrian Ciurea

3 joint publications

Andreas Kerschbaumer

3 joint publications

Hendrik Schulze-Koops